Pricing Log in Create free account
Saturday 17 October 2026 Export PODD’s income statement to Excel — free account

Insulet Corporation

PODD Healthcare Medical Devices

Insulet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 30.7% from fiscal 2024. In the quarter to June 2026, revenue grew 23.5%, EPS grew 328.1%, free cash flow fell 70.5% and total debt fell 32.2%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

141.10 2.33 +1.68%
Market cap
$9.6B
P/E
26.4×
Fwd P/E
24.7×
Dividend yield
—
F-score
6/9
Altman Z
9.09
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Insulet Corporation (PODD) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Insulet Corporation (PODD) trades at a EV/Sales of 3.3×. Over the past ten years it has ranged from 3.1× (September 2026) to 21.5× (November 2021); the current reading is higher than 1% of that period. That is above the Medical Devices industry median of 2.2× and in line with the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 7.5× (17.34%)
FY2024 9.0× 0.26%
FY2023 9.0× (42.87%)
FY2022 15.8× (6.26%)
FY2021 16.8× (8.63%)
FY2020 18.4× 24.88%
FY2019 14.8× 66.48%
FY2018 8.9× (1.02%)
FY2017 9.0× 49.59%
FY2016 6.0× (28.86%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 3.6× (31.26%)
Mar 2026 5.2× (30.07%)
Dec 2025 7.5× (14.30%)
Sep 2025 8.7× (8.16%)
42 more quarters

Against its own ten years

Low 3.1× High 21.5×
Ten-year median 9.7×
Current reading's percentile 1

EV/Sales against peers

Company EV/Sales
SNN Smith & Nephew SNATS, Inc. compare 1.5×
BRKR Bruker Corporation compare 2.9×
PODD Insulet Corporation 3.3×
GMED Globus Medical, Inc. compare 3.4×
BIO Bio-Rad Laboratories, Inc. compare 3.5×
BIO.B Bio-Rad Laboratories, Inc. compare 3.6×
HAE Haemonetics Corporation compare 4.7×
PEN Penumbra, Inc. compare 8.0×
GKOS Glaukos Corporation compare 15.9×
Medical Devices industry median 2.2×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on PODD